NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacyTakahiro Miyazaki, Jonathan Zalevsky, Murali K. Addepalli et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 55
NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Stephen K. Doberstein, Irene Choi et al.|Journal of Pharmacology and Experimental Therapeutics|2017Cited by 46
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trialsJonathan I. Silverberg, Jonathan Zalevsky, David Rosmarin et al.|Nature Communications|2024Cited by 37
NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cellsTanya O. Robinson, Kimberly S. Schluns, Shweta Hegde et al.|Journal of Clinical Investigation|2021Cited by 25
Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in RodentsCaroline Machado Kopruszinski, Frank Porreca, Juliana Swiokla et al.|Cellular and Molecular Neurobiology|2020Cited by 10